Harbor Capital Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$777K Buy
23,488
+7,921
+51% +$335K 0.06% 375
2025
Q4
$721K Buy
15,567
+418
+3% +$17.5K 0.06% 388
2025
Q3
$530K Sell
15,149
-2,735
-15% -$95.1K 0.04% 464
2025
Q2
$529K Sell
17,884
-2,957
-14% -$84.3K 0.02% 515
2025
Q1
$622K Sell
20,841
-6,309
-23% -$193K 0.03% 506
2024
Q4
$778K Buy
27,150
+3,652
+16% +$121K 0.03% 485
2024
Q3
$908K Buy
23,498
+983
+4% +$35.1K 0.04% 473
2024
Q2
$725K Buy
22,515
+8,842
+65% +$307K 0.06% 433
2024
Q1
$531K Buy
+13,673
New +$478K 0.07% 383

Other funds holding COLL